Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific's nomination committee proposes Dr. Gunnar Olsson and CEO Sten R. Sörensen as new members of the Board of Directors

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the nomination committee’s proposed resolutions for the 2024 annual general meeting includes the new election of Dr. Gunnar Olsson and Cereno’s CEO Sten R. Sörensen as new members of the Board of Directors. The nomination committee proposes re-election of board members Anders Svensson and Jeppe Øvlesen as well as new election of board members Dr. Gunnar Olsson and CEO Sten R. Sörensen.”Cereno is currently taking great strides in both

YIT has, for fulfilment of the terms of the convertible notes announced on 12 March 2024, resolved on a directed share issue of up to 16 million shares

YIT Corporation Stock Exchange Release 14 March 2024 at 18:10 p.m.YIT has, for fulfilment of the terms of the convertible notes announced on 12 March 2024, resolved on a directed share issue of up to 16 million shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA, SINGAPORE, NEW ZEALAND OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.YIT Corporation announced on 12 March 2024 a

The Nomination Committee’s proposed resolution to the Annual General Meeting on 16 April 2024

The Nomination Committee in Cereno Scientific AB (publ) (the “Company”) proposes the following resolutions to the Annual General Meeting on 16 April 2024, which relate to items 2 and 10-13 on the proposed agenda in the notice to the Annual General Meeting. In accordance with the principles adopted by the previous Annual General Meeting, the Nominating Committee has consisted of Cihan Punar, Sverker Jern, and Joakim Söderström.Election of chairperson of the meeting The Nomination Committee proposes Fredrik Brusberg, associate at MAQS Advokatbyrå, or, in the event of an impediment, the

Embrace the power of technology in Stellaris new expansion The Machine Age

Discover new possibilities and features for machine empires, a new Endgame Crisis, a new Crisis Path and much more in this major expansionSTOCKHOLM, MARCH 14 - Today, Paradox Interactive announced The Machine Age, a new expansion for its sci-fi strategy game Stellaris. Scientists have discovered advanced means to commune with the machine, enabling life to overcome the biological limitations of minds and flesh. The Machine Age begins a time of technical glory, but raises new ethical and social dilemmas. With those times of unleashed ambition, new threats will emerge, questioning the real

Cereno Scientific brings forward the publication of the Annual Report

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, has resolved to bring forward the publication of the Annual Report for the financial year 2023 to 26 March 2024Previously communicated was that the publication of the Annual Report for the financial year 2023 would take place during week 16, 2024, but the publication is now brought forward to 26 March 2024. The reason for the bringing forward the publication is that the Board of Directors has resolved to bring forward the Annual General Meeting to 16 April

Home Dialysis Risk Prevention Act addressed in House Committee on Ways and Means Hearing

On March 12, 2024, the House Committee on Ways and Means Chairman Jason Smith (MO-08) held a Hearing to examine opportunities and challenges in enhancing access to care in patients´ home and modernizing care in rural and underserved communities. The Hearing was titled, “Enhancing Access to Care at Home in Rural and Underserved Communities.” and during the Hearing Rep. Adrian Smith (NE-03) made the following remarks: “Thank you to all our witnesses for joining us today to talk about this important topic. It is amazing to see how new technologies have expanded the boundaries of access

White Pearl Technology Group postpones Annual Report 2023 and AGM

White Pearl Technology Group AB (WPTG) announces adjustments to its Financial Calendar, postponing the publication of the Annual Report for 2023 and the Annual General Meeting (AGM) for 2024. The Annual Report for 2023 will now be published on April 22nd, 2024, rather than the previously scheduled date of March 26th, 2024. Similarly, the AGM is rescheduled to take place on May 13th, 2024, instead of the initially communicated date of April 26th, 2024. Updated Financial Calendar 2024: Dates in 2024 22nd of April: Annual Report 2023 13th of May: Annual General Meeting 31st

#24-24 Split of shares in SBF Bostad AB

At the extraordinary general meeting of SBF Bostad AB (“the Company”) on March 7, 2024, it was decided to split the Company’s shares whereby one (1) existing share, regardless of share class, is split into ten (10) new shares (10:1) of the same share class. The board of the Company has now, with the support of the authorization from the extraordinary general meeting, decided that the record date for the split shall be March 19, 2024. The last day of trading before the split is March 15, 2024. The first day of trading after the split is March 18, 2024. Please note that the shares will be

New discovery reveals how the egg controls sperm entry

After the egg has been fertilized by a sperm, the surrounding egg coat tightens, mechanically preventing the entry of additional sperm and the ensuing death of the embryo. This is according to a new study led by researchers at Karolinska Institutet and published in the journal Cell. The work also explains how mutations in egg coat proteins can cause female infertility and may eventually lead to new contraceptive methods.Fertilization in mammals begins when a sperm attaches to the egg coat, a filamentous extracellular envelope that sperm must penetrate in order to fuse with the egg. Now an

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OFCERENO Scientific AB (PUBL)

The shareholders of Cereno Scientific AB (publ), company registration no. 556890-4071 (the “Company”), are hereby given notice to attend the Annual General Meeting to be held on Tuesday 16 April 2024 at 11 a.m. at MAQS Advokatbyrå’s premises, at the address Östra Hamngatan 24 in Gothenburg. Registration for the Annual General Meeting will commence at 10.30 a.m. Registration of attendance at the Annual General Meeting will be cancelled when the general meeting opens. Right to participate at the Annual General Meeting Any shareholder wishing to participate at the Annual General Meeting

Joint groundbreaking for Logistics Position Ramlösa in Helsingborg

On Thursday, March 14, a symbolic groundbreaking was held for the new Logistics Position Ramlösa in Helsingborg.14 March 2024, 15.30 p.m. CEST The groundbreaking for the 75,000 sqm logistic property was jointly performed by Jörgen Eriksson, CEO of Catena, Johan Kallin, CEO of Nowaste Logistics, Jan Björklund (S), Vice Chairman of the City Council of Helsingborg, and Alexander Svensson (M), Chairman of the City Planning Committee of Helsingborg City. An Aroma apple tree, the provincial apple of Skåne, was planted at the site in connection with the groundbreaking, intended to grow at the

Kongsberg Automotive has completed its share buyback program.

As previously announced, Kongsberg Automotive ASA (KA) has executed a buyback program of up to 2.5% of its outstanding shares in the market since November 17, 2023. Danske Bank has acted as an advisor for KA. Date Aggregated Daily Weighted Total Volume (# of Average Price Transaction Shares) (NOK) Value(NOK)March 05, 2024 300,000 1.63 490,620March 06, 2024 300,000 1.64 491,460March 07, 2024 300,000 1.64 491,580March 08,

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B62Z3C74 Issuer Name Fidelity China Special Situations PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An event changing the breakdown of voting rights 3. Details of person subject to the notification obligation Name FIL Limited City of registered office (if applicable) Hamilton Country of registered office (if applicable) Bermuda 4. Details of the shareholder Full name of shareholder(s) if different from

ABS Wavesight™ Nautical Systems Now Supports Fully Digital, Streamlined SIRE 2.0 Inspections

HSQE and Vetting Manager Module Enhancements Put ABS Wavesight™ Nautical Systems at the Forefront of the Transition to SIRE 2.0 (HOUSTON) — Enhancements to the HSQE and Vetting Manager module enable owners to transition to SIRE 2.0’s risk-based approach, which allows better management of areas of vulnerability, while also helping operators assess future vessel performance. The enhanced module now collects pre-inspection data, including areas of concern and risk assessment metrics that is compiled and digitized in one place and is easily transferable to inspectors transitioning

New data suggests Xoom PYUSD-based transfers could cut transfer costs by 25%

· Paypal has announced that it will be pairing its stablecoin PYUSD with its remittance arm, Xoom, to offer customers a fee-free remittance service. · FXC Intelligence analysis  using its in-house pricing data suggests that this could reduce the cost of sending remittances via Xoom by 25% when compared to its traditional remittance transfers, based on Paypal’s current pricing strategy. · This move has the potential to grow the adoption of PYUSD and, if handled correctly, relaunch Xoom, which until

Transfer of own shares as a directed share issue based on share-based incentive scheme

Neste Corporation, Stock Exchange Release, 14 March 2024 at 4 p.m. (EET)Neste Corporation has on 14 March 2024 transferred a total of 13 786 treasury shares without consideration to the participants of Neste Group's Performance Share Plan 2021-2023 and the Restricted Share Plan 2021-2023 as share rewards based on the terms and conditions of these plans. The plans are part of the share-based incentive scheme 2019 of Neste, announced with a stock exchange release on 11 December 2018.The transfer of own shares is implemented as a directed share issue without consideration based on a

Lantmännen in meetings with the Prime Minister and the Minister for Rural Affairs – talks on Food Strategy 2.0 and increased profitability for agriculture

Lantmännen has had several meetings with ministers in March with the aim of developing Swedish food production and Swedish agriculture to become as strong, profitable and robust as possible.Tuesday, March 12. Meeting with Prime Minister Ulf Kristersson and Minister for Rural Affairs Peter Kullgren. Per Lindahl, Chairman of the Board of Lantmännen and a farmer, met with the Prime Minister and the Minister for Rural Affairs for a discussion on increased competitiveness and profitability in agriculture. The meeting had several topics on the agenda, including more expensive external factors,

Nordic Capital to invest in leading digital insurance payments network One Inc to drive continued growth and product innovation

Strategic investment will support One Inc’s mission to digitalize and modernize the insurance industryFolsom, CA, March 14, 2024 – Nordic Capital, one of the most active and experienced investors in Technology & Payments globally, today announced that it will join Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, as an investor in One Inc (the “Company”), a digital payments platform specializing in modernizing the insurance industry in North America. Great Hill Partners invested in One Inc in 2020 and will retain an equal stake to Nordic Capital

UPM supplements its Remuneration Policy to be presented for the Annual General Meeting on 4 April 2024

UPM-Kymmene Corporation        Stock Exchange Release (Other information disclosed according to the rules of the Exchange)        14 March 2024 at 16:00 EET UPM supplements its Remuneration Policy to be presented for the Annual General Meeting on 4 April 2024 UPM has today supplemented its Remuneration Policy to be presented for the Annual General Meeting on 4 April 2024. Amendment is made to section “5.2 CEO’s service agreement” by adding information on the President and CEO’s existing termination benefits from the corporate website to this section. The supplemented Remuneration

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

Bioretec Ltd    Inside information       14 March 2024 at 3.45 p.m. EETBioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation for its RemeOs™ Spinal Interbody Cage implant from the US Food and Drug Administration, confirming that the product represents a breakthrough technology in spinal surgery. RemeOs Spinal Interbody Cages are intended to be used to restore intervertebral height and facilitate intervertebral body fusion in the cervical spine. Obtaining the Breakthrough Device Designation status is an important milestone in

Vestas wins order from Sempra infrastructure to build a 319 MW wind farm in Mexico

News release from Vestas Latin AmericaSão Paulo, March 14, 2024 Sempra Infrastructure, a subsidiary of Sempra, has placed a 319 MW order for the Cimarron wind farm in Tecate, in the state of Baja California, Mexico. This is the third phase of the Energia Sierra Juarez Wind Complex that will have a total installed capacity of 582 MW. The order includes supply and installation of 46 V163-4.5 MW turbines and 18 V162-6.2 MW turbines. Upon completion, Vestas will also deliver a 10-year service agreement (AOM 5000) that will optimise energy production while providing long-term business

Mellozzan[® ](melatonin) have gained marketing approval in the UK

EQL's key product Mellozzan[®] has now gained marketing approval by the Health Authorities in the UK, where it is to be provided to patients by EQL's license partner Medice Arzneimittel Pütter GmbH & Co. KG. Launch of Mellozzan in the UK is planned for the financial year 2024/25, subject to reimbursement approvals and manufacturing capabilities. In addition to the UK the licensee also has ongoing work for registrations and subsequent launches in Finland and Switzerland. In 2023, Medice launched Mellozzan[®] in Denmark and Norway and launch preparations are nearing completion in Germany and

There are no items matching the current filter
There are no more items matching the current filter
Back to top